Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 695 of 1,261
  1. US 9333245

    Methods and compositions for treating wounds and reducing the risk of incisional hernias

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted
  2. US 9333171

    Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted
  3. US 9333258

    Fine spatiotemporal control of fat removal using NIR light

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted
  4. US 9334245

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted May 10, 2016 · Expires May 5, 2036

    granted
  5. US 9333251

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 10, 2016 · Expires May 5, 2036

    granted
  6. US 9333244

    Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia

    HALOZYME, INC. · Granted May 10, 2016 · Expires May 5, 2036

    granted
  7. US 9333195

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted May 10, 2016 · Expires May 5, 2036

    granted
  8. US 9333267

    Thiol-selective water-soluble polymer derivatives

    Nektar Therapeutics · Granted May 10, 2016 · Expires May 5, 2036

    granted
  9. US 9334235

    Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging

    Phenomenome Discoveries Inc. · Granted May 10, 2016 · Expires May 5, 2036

    granted
  10. US 9333264

    Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted
  11. US 9334495

    Minor groove binder (MGB)-oligonucleotide miRNA antagonists

    ELITECHGROUP B.V. · Granted May 10, 2016 · Expires May 5, 2036

    granted
  12. US 9333200

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted May 10, 2016 · Expires May 5, 2036

    granted
  13. US 9333148

    Polymerizable composition and dental material

    KURARAY NORITAKE DENTAL INC. · Granted May 10, 2016 · Expires May 5, 2036

    granted
  14. US 9333259

    Selective fat removal using NIR light and nanoparticles

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted
  15. US 9333248

    Methods and composition related to Th-1 dendritic cells

    The Board of Regents of the University of Texas System · Granted May 10, 2016 · Expires May 5, 2036

    granted
  16. US 9334250

    Multifunctional radical quenchers for the treatment of mitochondrial dysfunction

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 10, 2016 · Expires May 5, 2036

    granted
  17. US 9334246

    Substituted triazines for malaria treatment and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted May 10, 2016 · Expires May 5, 2036

    granted
  18. US 9334364

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted May 10, 2016 · Expires May 5, 2036

    granted
  19. US 9333237

    Bone morphogenic protein binding peptide

    The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) · Granted May 10, 2016 · Expires May 5, 2036

    granted
  20. US 9334306

    Leukemia stem cell targeting ligands and methods of use

    The Regents of the University of California · Granted May 10, 2016 · Expires May 5, 2036

    granted
  21. US 9334244

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 10, 2016 · Expires May 5, 2036

    granted
  22. EP 3013366

    KOMBINATIONSTHERAPIE MIT EINEM FAKTOR XII-HEMMER UND EINEM C1-HEMMER

    CSL BEHRING GMBH [DE] · Granted May 4, 2016 · Expires Apr 29, 2036

    granted
  23. US 9326958

    Compositions for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted May 3, 2016 · Expires Apr 28, 2036

    granted
  24. US 9328129

    Peptidomimetic inhibitors of PSMA

    The Regents of the University of California · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.